Ebola outbreak: what's driving the fastest-growing epidemic on record in eastern Congo

The Ebola virus has killed more than 1,700 people in eastern Democratic Republic of Congo (DRC), in what STAT News describes as the fastest-growing outbreak of the disease on record.

Ebola virus disease is a severe viral hemorrhagic fever first identified in 1976 near the Ebola River in what is now the DRC. Its case fatality rate has historically varied widely depending on the viral strain involved and how quickly patients can access medical care.

The virus spreads through direct contact with the blood and bodily fluids of infected people, living or dead, or with contaminated materials and animals. Fruit bats are considered the likely natural reservoir, and human-to-human transmission, particularly in densely populated communities, during funeral practices, and in healthcare settings lacking adequate protective measures, is what typically accelerates outbreaks.

Symptoms usually begin abruptly with fever, severe headache, muscle pain, weakness, fatigue, sore throat, vomiting and diarrhea; in more severe cases, internal or external bleeding can follow. The incubation period ranges from 2 to 21 days.

DRC has recorded more Ebola outbreaks than any other country since 1976, with more than a dozen on record. Part of the reason is the country's proximity to the virus's natural reservoir range; another is that ongoing conflict and weak health infrastructure in some affected regions have complicated outbreak response.

The significance of describing an outbreak as 'fastest-growing' lies in how rapid case growth strains contact tracing, treatment-center capacity, and vaccine and therapeutic supply chains. Historically, more slowly growing outbreaks could be contained before spreading widely, so a fast-growing outbreak signals particular urgency for response teams.

Available prevention and treatment tools include a licensed vaccine, rVSV-ZEBOV, sold under the brand name Ervebo, which has been used in ring-vaccination strategies during previous DRC outbreaks. Certain monoclonal antibody treatments approved in recent years improve survival odds when patients reach care early, while supportive care involving fluid and electrolyte replacement remains central to treatment.

Deploying vaccines and treatments in real time to remote or conflict-affected areas of eastern Congo has historically proven difficult; in past outbreaks in the region, including the 2018-2020 Kivu outbreak, community mistrust and insecurity slowed containment efforts alongside health workers.

The World Health Organization and international partners typically classify large Ebola outbreaks under emergency response frameworks, coordinating with national health ministries, and case and death counts are generally revised as more suspected cases are confirmed through laboratory testing.

As the outbreak continues to grow, according to STAT News's reporting, health officials' most urgent priorities remain accelerating vaccine access, expanding treatment capacity, and improving community engagement to slow transmission chains before the toll rises further.